Back to today’s briefing

Story perspectives

FDA Approves 2026–27 COVID, Authorizes Moderna Flu Vaccine

8/29/2026

26 3 Full Breakdown

Summary

Story summary

FDA approved updated COVID-19 vaccines for the 2026-27 season on Aug 27-28 2026.
FDA also authorized Moderna’s mFlusiva mRNA flu vaccine for adults 50 years and older.
Moderna’s mFlusiva showed 26.6 % higher effectiveness than traditional flu shots in >40,000-person trials.
Approvals proceeded despite a federal court ruling that left the CDC advisory panel in legal limbo.
Medicare and major private insurers will cover the updated COVID-19 vaccines.

1 of 1

Story summary

FDA approved updated COVID-19 vaccines for the 2026-27 season on Aug 27-28 2026.
FDA also authorized Moderna’s mFlusiva mRNA flu vaccine for adults 50 years and older.
Moderna’s mFlusiva showed 26.6 % higher effectiveness than traditional flu shots in >40,000-person trials.
Approvals proceeded despite a federal court ruling that left the CDC advisory panel in legal limbo.
Medicare and major private insurers will cover the updated COVID-19 vaccines.